VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $87 | +10.1% | 1,153 | 0.0% | 0.06% | +12.0% |
Q1 2024 | $79 | +507.7% | 1,153 | +451.7% | 0.05% | +455.6% |
Q4 2023 | $13 | +18.2% | 209 | 0.0% | 0.01% | +12.5% |
Q3 2023 | $11 | – | 209 | +4080.0% | 0.01% | – |
Q2 2023 | $0 | – | 5 | -16.7% | 0.00% | – |
Q1 2023 | $0 | -100.0% | 6 | -80.0% | 0.00% | -100.0% |
Q4 2022 | $2 | – | 30 | +233.3% | 0.00% | – |
Q3 2022 | $0 | – | 9 | -10.0% | 0.00% | – |
Q2 2022 | $0 | – | 10 | -23.1% | 0.00% | – |
Q1 2022 | $0 | – | 13 | -23.5% | 0.00% | – |
Q4 2021 | $0 | – | 17 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,049,893 | $53,523,545 | 17.09% |
Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $40,429,128 | 16.12% |
Kynam Capital Management, LP | 1,302,407 | $66,396,709 | 10.86% |
RA Capital Management | 7,891,254 | $402,296,129 | 7.92% |
COMMODORE CAPITAL LP | 1,100,000 | $56,078,000 | 6.56% |
GREAT POINT PARTNERS LLC | 531,211 | $27,081,137 | 4.93% |
ACUTA CAPITAL PARTNERS, LLC | 121,022 | $6,169,702 | 4.14% |
Frazier Life Sciences Management, L.P. | 1,164,405 | $59,361,367 | 3.94% |
Novo Holdings A/S | 845,000 | $43,078,100 | 3.18% |
BRAIDWELL LP | 1,619,553 | $82,564,812 | 2.61% |